Compare CYRX & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | PDX |
|---|---|---|
| Founded | 1999 | 2019 |
| Country | United States | NY |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 814.9M | 945.1M |
| IPO Year | 2008 | 2018 |
| Metric | CYRX | PDX |
|---|---|---|
| Price | $17.33 | $20.31 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $13.31 | N/A |
| AVG Volume (30 Days) | ★ 461.1K | 112.7K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.95% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.61 | $18.47 |
| 52 Week High | $17.98 | $25.14 |
| Indicator | CYRX | PDX |
|---|---|---|
| Relative Strength Index (RSI) | 64.76 | 27.93 |
| Support Level | $14.55 | $19.95 |
| Resistance Level | N/A | $20.36 |
| Average True Range (ATR) | 0.56 | 0.37 |
| MACD | 0.12 | -0.11 |
| Stochastic Oscillator | 82.74 | 9.28 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.